Simcere Unveils Latest Clinical Data of Iguratimod and Abatacept at EULAR
Simcere Published its First Environmental, Social and Governance (ESG) Report
Simcere Will Announce Progress of Multiple Clinical Research on Antitumor Drugs at the 2021 ASCO Annual Meeting
Simcere Enters into Partnership with Kazia Therapeutics for Paxalisib in Greater China
The Clinical Study Data for Sanbexin® was Published in the International Leading Neurology Medical Journal “STROKE”
Simcere Officially Listed on HKEX
Simcere and G1 Therapeutics Announce Exclusive License Agreement for Trilaciclib in Greater China
Sanbexin® (Edaravone and Dexborneol Concentrated Solution for Injection) was Approved by NMPA on the Chinese Market
Simcere and Primary Peptides Launch Exclusive China Partnership
Clinical Data of Envafolimab to be Released at ASCO 2020